32 related articles for article (PubMed ID: 18507782)
1. Foxp3⁺ regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice.
Blankenhaus B; Reitz M; Brenz Y; Eschbach ML; Hartmann W; Haben I; Sparwasser T; Huehn J; Kühl A; Feyerabend TB; Rodewald HR; Breloer M
PLoS Pathog; 2014 Feb; 10(2):e1003913. PubMed ID: 24516385
[TBL] [Abstract][Full Text] [Related]
2. Gene expression patterns associated with Leishmania panamensis infection in macrophages from BALB/c and C57BL/6 mice.
Restrepo CM; Llanes A; Herrera L; Ellis E; Lleonart R; Fernández PL
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009225. PubMed ID: 33617537
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit.
Hart PH; Grimbaldeston MA; Hosszu EK; Swift GJ; Noonan FP; Finlay-Jones JJ
Immunology; 1999 Nov; 98(3):352-6. PubMed ID: 10583593
[TBL] [Abstract][Full Text] [Related]
4. Contributions of Diet and Age to Ulcerative Dermatitis in Female C57BL/6J Mice.
Gozalo AS; Zerfas PM; Qin J; Alves DA; Akkaya M; Peña MY; Elkins WR
Comp Med; 2023 Mar; 73(2):109-19. PubMed ID: 36882188
[TBL] [Abstract][Full Text] [Related]
5.
Sánchez-García L; Pérez-Torres A; Gudiño-Zayas ME; Zamora-Chimal J; Meneses C; Kamhawi S; Valenzuela JG; Becker I
Pathogens; 2023 Jan; 12(2):. PubMed ID: 36839479
[No Abstract] [Full Text] [Related]
6. Mast-Cell Response to
Sánchez-García L; Pérez-Torres A; Muñoz-Cruz S; Salaiza-Suazo N; Morales-Montor J; Becker I
Pathogens; 2022 Mar; 11(4):. PubMed ID: 35456073
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Mast Cells in Parasitic Protozoan Infections.
Lu F; Huang S
Front Immunol; 2017; 8():363. PubMed ID: 28428784
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils and mast cells in leishmaniasis.
Rodríguez NE; Wilson ME
Immunol Res; 2014 Aug; 59(1-3):129-41. PubMed ID: 24838146
[TBL] [Abstract][Full Text] [Related]
10. Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
Fernández-Figueroa EA; Rangel-Escareño C; Espinosa-Mateos V; Carrillo-Sánchez K; Salaiza-Suazo N; Carrada-Figueroa G; March-Mifsut S; Becker I
PLoS Negl Trop Dis; 2012; 6(5):e1533. PubMed ID: 22629474
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
12. Finding a model for the study of Leishmania (Leishmania) mexicana infection: The Yucatan Deer mouse (Peromyscus yucatanicus) as a suitable option.
Loría-Cervera EN; Sosa-Bibiano EI; Van Wynsberghe NR; Andrade-Narváez FJ
Acta Trop; 2018 Nov; 187():158-164. PubMed ID: 30092224
[TBL] [Abstract][Full Text] [Related]
13. Immune response to Leishmania mexicana: the host-parasite relationship.
Rodríguez-Serrato MA; Salinas-Carmona MC; Limón-Flores AY
Pathog Dis; 2020 Nov; 78(8):. PubMed ID: 33016312
[TBL] [Abstract][Full Text] [Related]
14. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
[TBL] [Abstract][Full Text] [Related]
15. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
16. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
Wershil BK; Theodos CM; Galli SJ; Titus RG
J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
